These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22174643)

  • 1. Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?
    Gajofatto A; Bongianni M; Zanusso G; Benedetti MD; Monaco S
    Int J Mol Sci; 2011; 12(11):7960-70. PubMed ID: 22174643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.
    Gajofatto A; Calabrese M; Benedetti MD; Monaco S
    Dis Markers; 2013; 35(6):687-99. PubMed ID: 24324285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 14-3-3 protein in multiple sclerosis: a marker of disease severity.
    Colucci M; Roccatagliata L; Capello E; Narciso E; Latronico N; Tabaton M; Mancardi GL
    Mult Scler; 2004 Oct; 10(5):477-81. PubMed ID: 15471360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases.
    Gajofatto A; Monaco S; Fiorini M; Zanusso G; Vedovello M; Rossi F; Turatti M; Benedetti MD
    Arch Neurol; 2010 Jun; 67(6):724-30. PubMed ID: 20558391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis.
    Frederiksen J; Kristensen K; Bahl JM; Christiansen M
    Mult Scler; 2012 May; 18(5):592-9. PubMed ID: 21969238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.
    Pietroboni AM; Schiano di Cola F; Scarioni M; Fenoglio C; Spanò B; Arighi A; Cioffi SM; Oldoni E; De Riz MA; Basilico P; Calvi A; Fumagalli GG; Triulzi F; Galimberti D; Bozzali M; Scarpini E
    Mult Scler; 2017 Jul; 23(8):1085-1091. PubMed ID: 27754941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients.
    Rommer PS; Kamin F; Petzold A; Tumani H; Abu-Mugheisib M; Koehler W; Hoffmann F; Winkelmann A; Benecke R; Zettl UK
    Mol Diagn Ther; 2014 Dec; 18(6):631-7. PubMed ID: 24986188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
    Bartosik-Psujek H; Archelos JJ
    J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis.
    Jiménez-Jiménez FJ; Zurdo JM; Hernanz A; Medina-Acebrón S; de Bustos F; Barcenilla B; Sayed Y; Ayuso-Peralta L
    Acta Neurol Scand; 2002 Dec; 106(6):351-4. PubMed ID: 12460140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebrospinal fluid diagnostics in multiple sclerosis].
    Ruprecht K; Tumani H
    Nervenarzt; 2016 Dec; 87(12):1282-1287. PubMed ID: 27649986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
    Gajofatto A; Bongianni M; Zanusso G; Bianchi MR; Turatti M; Benedetti MD; Monaco S
    Acta Neurol Scand; 2013 Nov; 128(5):336-44. PubMed ID: 23550839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update.
    Lo Sasso B; Agnello L; Bivona G; Bellia C; Ciaccio M
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31167509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Sugano H; Hara T; Fusegi K; Karagiozov K; Arai H
    J Neurol Sci; 2015 Oct; 357(1-2):88-95. PubMed ID: 26169158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
    Møllgaard M; Degn M; Sellebjerg F; Frederiksen JL; Modvig S
    Eur J Neurol; 2016 May; 23(5):898-905. PubMed ID: 26872061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
    PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.
    Gastaldi M; Zardini E; Franciotta D
    Expert Rev Mol Diagn; 2017 Jan; 17(1):31-46. PubMed ID: 27911122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system.
    Matute-Blanch C; Montalban X; Comabella M
    Handb Clin Neurol; 2017; 146():67-84. PubMed ID: 29110780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid biomarkers in multiple sclerosis.
    Tumani H; Hartung HP; Hemmer B; Teunissen C; Deisenhammer F; Giovannoni G; Zettl UK;
    Neurobiol Dis; 2009 Aug; 35(2):117-27. PubMed ID: 19426803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid proteomics in multiple sclerosis.
    Kroksveen AC; Opsahl JA; Guldbrandsen A; Myhr KM; Oveland E; Torkildsen Ø; Berven FS
    Biochim Biophys Acta; 2015 Jul; 1854(7):746-56. PubMed ID: 25526888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.